Nautilus Biotechnolgy, Inc. (NAUT)
NASDAQ·Healthcare·Biotechnology
$2.89
—
Mkt Cap $367.77M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
Implied Upside
-13.5%
Consensus $2.50 vs current $2.89
NASDAQ·Healthcare·Biotechnology
$2.89
—
Mkt Cap $367.77M
No recent rating data.
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
-13.5%
Consensus $2.50 vs current $2.89